BioCentury
ARTICLE | Company News

Par Pharmaceutical sales and marketing update

September 21, 2015 7:00 AM UTC

Par launched its testosterone gel 1%, a generic version of AndroGel 1% from AbbVie Inc. (NYSE:ABBV, Chicago, Ill.). AndroGel is marketed as testosterone replacement therapy. The wholesale acquisitio...